KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Income towards Parent Company: 2010-2025

Historic Income towards Parent Company for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to -$202.4 million.

  • Novavax's Income towards Parent Company fell 66.84% to -$202.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.7 million, marking a year-over-year increase of 219.97%. This contributed to the annual value of -$187.5 million for FY2024, which is 65.60% up from last year.
  • As of Q3 2025, Novavax's Income towards Parent Company stood at -$202.4 million, which was down 290.01% from $106.5 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Income towards Parent Company peaked at $518.6 million during Q1 2025, and registered a low of -$846.3 million during Q4 2021.
  • In the last 3 years, Novavax's Income towards Parent Company had a median value of -$121.3 million in 2024 and averaged -$28.2 million.
  • In the last 5 years, Novavax's Income towards Parent Company crashed by 1,910.83% in 2021 and then skyrocketed by 451.51% in 2025.
  • Novavax's Income towards Parent Company (Quarterly) stood at -$846.3 million in 2021, then soared by 78.46% to -$182.2 million in 2022, then rose by 2.12% to -$178.4 million in 2023, then spiked by 54.58% to -$81.0 million in 2024, then tumbled by 66.84% to -$202.4 million in 2025.
  • Its last three reported values are -$202.4 million in Q3 2025, $106.5 million for Q2 2025, and $518.6 million during Q1 2025.